Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens

C Baudouin1, N Haouat, F Brignole

  • 1Department of Ophthalmology, Saint-Roch Hospital, Nice, France.

Insights

Impression cytology detects conjunctival inflammation by identifying inflammatory markers like HLA DR and CD23. This non-invasive method aids in diagnosing ocular surface disorders, including dry eye and chronic conjunctivitis.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Impression cytology is a non-invasive technique for evaluating conjunctival epithelium.
  • Inflammatory markers play a crucial role in ocular surface disorders.

Purpose of the Study:

  • To investigate the expression of inflammatory markers, human leukocyte antigen DR (HLA DR) and the receptor to IgE (CD23), in conjunctival epithelium using impression cytology.
  • To assess the utility of these markers in diagnosing ocular surface inflammation, including chronic conjunctivitis and dry eye syndrome.

Main Methods:

  • Impression cytology specimens were obtained from 80 patients.
  • Indirect immunofluorescence was used to detect HLA DR and CD23 expression.
  • Specimens were analyzed from normal subjects, patients with chronic conjunctivitis, and patients with dry eye syndrome.

Main Results:

  • Normal conjunctival cells showed no reactivity for HLA DR or CD23.
  • Patients with chronic conjunctivitis exhibited 40-100% positivity for one or both markers in epithelial and goblet cells.
  • Patients with dry eye on treatment showed moderate to strong positivity for HLA DR and/or CD23, suggesting inflammation beyond tear deficiency.

Conclusions:

  • Immunocytological detection of HLA DR and CD23 is a valuable tool for investigating conjunctival inflammation and allergy.
  • These methods can aid in the diagnosis and treatment of ocular surface disorders, including dry eye and allergic conjunctivitis.
  • Marker expression may indicate local inflammation, potentially linked to treatments, in dry eye patients.